Lipid and metabolic disorders – including dyslipidemia, atherosclerotic cardiovascular disease, familial hypercholesterolaemia, and PCSK9-associated conditions – create complex challenges across lipid management, cardiovascular prevention, and therapeutic development. As novel lipid-lowering agents and precision medicine approaches reshape clinical practice, comprehensive real-world evidence is vital to illuminate treatment pathways, address management gaps, and accelerate innovation in lipid-driven cardiovascular disease.
Adelphi Real World’s Disease Specific Programmes (DSPs) are designed to address these needs.
Our DSPs deliver comprehensive real-world data addressing lipid disorder complexity. Through collaboration with lipidologists and patients, we capture critical insights on:
Diagnostic & Risk Management Approaches
Explore lipid screening practices, risk assessment methodologies, diagnostic pathways, and the clinical frameworks shaping lipid management across healthcare environments.
Treatment Patterns & Therapeutic Adoption
Examine real-world therapy selection, sequencing of lipid-lowering agents, uptake of novel therapeutics, and treatment effectiveness in clinical practice.
Patient Outcomes & Cardiovascular Impact
Understand patient-reported outcomes, adherence patterns, cardiovascular risk reduction, and quality of life improvements across lipid disorder populations.
Treatment Optimisation Gaps
Recognise barriers to optimal lipid control and opportunities for innovative solutions to better serve underserved lipid disorder patients.
Heart Rhythm & Structural Disorder Disease Specific Programmes (DSPs) Portfolio
Why Partner with Adelphi Real World?
Lipid Disease Specialisation
Expertise in lipid pathophysiology combined with robust methodology.
Authentic Patient Insights
Real patient experiences drive evidence-informed therapeutic innovation.
Multi-Market Research
Comparative analysis across global healthcare systems and treatment practices.
Commercial Support
Evidence for clinical strategy, market access, and stakeholder communication.
Current Countries Lipid & Metabolic Disorder DSPs Cover
Our Collaborative Model
We engage with pharmaceutical innovators, specialist lipid centres, cardiologists, patient communities, and policymakers to generate evidence that deepens understanding of lipid disease and accelerates development of breakthrough lipid-management therapies.
Interested in Our Lipid & Metabolic Disorder Research?
-
Arrange a Consultation: Meet with our lipid specialists to discuss how real-world evidence can advance your lipid management programmes.
-
Get Customised Insights: Curious about our methodology, geographic reach, or disease applications? Contact us for tailored resources.
Transform your lipid and metabolic disease research with Adelphi Real World’s comprehensive DSP solutions. Together, we can enhance understanding of lipid pathology, accelerate innovation, and ultimately deliver better cardiovascular outcomes for lipid disorder patients.
Contact us today using the form below.
Heart Rhythm & Structural Disorders DSPs
Conferences Attending
Other Services